Brad Michel

In our latest Pulse of Change survey, we polled 2,800 C-suite executives across 18 countries to see if GenAI is living up to the hype. Here are a few key takeaways: - Almost 100% of C-suite leaders acknowledge Gen AI's influence on customer acquisition and retention. - 65% see the technology as a key driver for revenue growth, and 35% recognize its impact on cost reduction. - 54% of leaders have already integrated Gen AI into their customer strategies, enhancing services with chatbots that offer real-time, personalized interactions. - 49% of C-suite leaders report that their Gen AI investments are outperforming other technologies. To make the survey user-friendly, we’ve made it searchable by industry, geography or role. You can access the Pulse of Change survey here: https://lnkd.in/e478hJ_X  #GenAI #PulseOfChange #BusinessStrategy #Csuite Jack Azagury, Karalee Close, Michael Benyamin, Elena Pienkowski

118

1 Comment

Life science’s CRM systems need to deliver personalized experiences, boost engagement and drive growth, but that’s unlikely without a radical rethink. ZS’s Mahmood Majeed and Srihari Sarangan share the vision for the next-gen CRM: https://bit.ly/3Te1jwN #Lifesciences #CRM #CommercialModel

2

As we enter 2025, the healthcare and life sciences industries are focusing on steady, foundational change rather than sudden disruption. Discover how SAS anticipates convergence, technology modernization, and patient empowerment will influence the coming year: https://lnkd.in/efvpDvM4

1

Transforming a global biotech company like Biogen involves navigating complex challenges and making strategic decisions. In a recent conversation with BCG’s Torben Danger, Biogen CFO Mike McDonnell discusses its Fit for Growth initiative. My key takeaways: 1. Core Focus: Prioritizing top-line growth, margin expansion, and efficient capital allocation is crucial for management. 2. Employee Engagement: Empowering employees to redesign their organizations fosters creativity and maintains an entrepreneurial spirit. 3. Strategic Investments: Acquisitions like Reata Pharmaceuticals highlight Biogen's commitment to innovative treatments and diversification into rare diseases. 4. AI Implementation: Leveraging AI for efficiency, particularly in R&D, underscores the potential of technology to drive growth and innovation. To learn about Biogen's impressive people first transformation journey, read the full interview -   #CostManagement

9

How can pharma transform both their employees and their environment to successfully become a patient-centric organization? In this episode of the “Patient Centricity Podcast,” host Victoria Summers welcomes Principal Emeritus Torsten Bernewitz of ZS’s global change management expertise center. They discuss shifting the mindsets and behaviors of the people in an organization, with examples and tools to bring this to life. Listen to part one of this two-part series: https://apple.co/3Czg9Z2

8

How can pharma transform both their employees and their environment to successfully become a patient-centric organization? In this episode of the “Patient Centricity Podcast,” host Victoria Summers welcomes Principal Emeritus Torsten Bernewitz of ZS’s global change management expertise center. They discuss shifting the mindsets and behaviors of the people in an organization, with examples and tools to bring this to life. Listen to part one of this two-part series: https://apple.co/3Czg9Z2

5

Engaging patients is key to evolving #ValueBasedCare. #Accenture’s Asher Perzigian emphasizes the transformative impact on enhancing care experiences and outcomes. To adapt to the changing healthcare landscape, organizations must reinvent themselves and focus on patient-centered strategies. Read more: https://accntu.re/3NbUsAs

12

Patient engagement is no longer optional—it’s essential for life sciences companies. In this article, my colleagues explore how global patient engagement strategies are evolving and identify three critical dimensions of consideration to make patient engagement actionable and effective: https://bit.ly/3WCudYi

12

🚀 Generative AI is transforming healthcare! 🚀 Deloitte's latest insights explore how generative AI is revolutionizing patient care, medical research, and operational efficiency in the healthcare industry. From enhancing clinical decision-making to personalizing patient interactions, AI is set to reshape the future of healthcare. However, challenges like data privacy and the need for robust governance remain crucial to address as we navigate this AI-driven evolution. Discover how AI is changing the game 🏥🤖

21

1 Comment

Unlocking the full potential of patient journey insights is pivotal for pharma companies dedicated to improving patient outcomes. Takeda and ZS have collaborated to reimagine this process, developing a modular framework to power scaled real-world data analytics. This approach provides profound and timely insights into patient experiences and unmet needs. By democratizing data access, this innovation enables teams to make informed, patient-centric decisions throughout the entire product life cycle: https://bit.ly/3YwfU8u #PatientJourney #PharmaInnovation #RealWorldData #PatientCentricity #HealthcareAnalytics

11

1 Comment

Generative AI is already transforming #healthcare, from R&D to precision medicine. #GenAI can create new content from vast data sets, redefining diagnosis, optimizing treatments, and extending care beyond traditional boundaries. The shift is happening now—far from distant or futuristic! Read the full article: https://on.bcg.com/4f82WVH

15

Have you been following the ‘Biopharma R&D Leadership Agenda’ series? We've reached the final installment, and it's a critical read for biopharma leaders aiming to drive transformational change within their organizations. The latest article, "Empowered Workforce," delves into the complexities of modern operating models and processes that often hinder efficiency and disempower teams. It highlights how BCG-supported process and governance redesigns have significantly simplified operations, enhanced responsiveness, and enabled teams to achieve outstanding results. Read the article here: https://lnkd.in/dqwz3VGn Let me know your thoughts in the comments below.

9

From accelerating R&D with #GenAI to a deeper look at the patient-health care provider relationship, see how executives are navigating a year of transformation so far for #lifesciences in Deloitte's Global #LSOutlook24.

26

GenAI’s potential in #healthcare extends across diagnostics, patient care, and beyond. Imagine AI-powered tools that streamline patient interactions, refine diagnosis, and optimize treatments—all while lowering costs. The tech is reshaping the value of care and patient outcomes in real time. Learn more: https://on.bcg.com/3Z6ymX7

11

1 Comment

Explore Deloitte’s report (authored by 3 of my esteemed colleagues) to learn how 3 #CellAndGene therapy pricing models could help transform how CGT therapies are financed. https://deloi.tt/3RE72Lm

10

In the healthcare sector, disruption has emerged as a key indicator of progress. Accenture's Smriti Kirubanandan shares his perspective on disruption for good, welcoming innovation and spearheading transformative breakthroughs. Read the Forbes article: https://accntu.re/3IwZd5v #Healthcare #Accenture

5

1 Comment

An agile, customer-centric approach allows life sciences companies to flex and move forward as the world changes, whether that’s in response to regulation or competitive dynamics, technological change or an expanding stakeholder landscape. Most of all, this approach anchors the business to the customer, and fundamentally shifts the operating model to deliver better customer experience and commercial value. Read this article to find out how agile customer-centricity can make a significant difference in your Customer & Growth efforts.

3

Will technology create seamless experiences for patients, providers, and payers? @Dan Galdenzi, head of EY Nexus for Health, is leading the charge. Discover their groundbreaking work in healthcare interoperability, data sharing, and more. Tune in to hear Dan's insights with Sandy Vance. Listen here: ow.ly/CeHT50RGMmx #interoperability #digitalhealth #healthit

10

1 Comment